CHAMPIONS ONCOLOGY, INC. (CSBR)
2025-07-31 | 2024-10-31 | 2024-07-31 | ||
|---|---|---|---|---|
| Oncology revenue | 13,995 | 13,489 | 14,061 | |
| Sales and marketing | 1,855 | 1,751 | 1,679 | |
| Research and development | 2,082 | 1,689 | 1,454 | |
| General and administrative | 2,570 | 1,889 | 2,527 | |
| Loss on disposal of equipment | -20 | - | - | |
| Cost of oncology revenue | 7,995 | 7,428 | 7,072 | |
| Total costs and operating expenses | 14,522 | 12,757 | 12,732 | |
| (loss) income from operations | -527 | 732 | 1,329 | |
| Other income, net | 75 | 7 | 5 | |
| (loss) income before provision for income taxes | -452 | 739 | 1,334 | |
| Provision for income taxes | 14 | 11 | 21 | |
| Net (loss) income | -466 | - | - | |
| Less net loss attributable to noncontrolling interest | -30 | - | - | |
| Net (loss) income attributable to company's common shares | -436 | 728 | 1,313 | |
| And diluted (in shares) | 13,788,414 | 14,016,953 | 14,042,379 | |
| Basic (in dollars per share) | -0.03 | 0.05 | 0.1 | |
| Basic (in shares) | 13,788,414 | 13,593,766 | 13,593,766 | |
| Diluted (in dollars per share) | -0.03 | 0.05 | 0.09 | |